Difficulty: Medium
Average Score: 82%
Practice
The preferred estrogen for hormone replacement therapy in menopausal women is
Correct answer
D
Rationale
The correct answer is D) Conjugated estrogens. In the context of hormone replacement therapy in menopausal women, conjugated estrogens are preferred due to their balanced combination of estrogens that closely mimic the natural hormones produced by the ovaries before menopause. This makes them more effective in alleviating menopausal symptoms and reducing the risk of osteoporosis and cardiovascular diseases.
Option A, Ethinylestradiol, is not typically used in hormone replacement therapy for menopausal women because it is more commonly found in oral contraceptives.
Option B, Estradiol benzoate, is a form of estradiol that is not as commonly used as conjugated estrogens for hormone replacement therapy in menopausal women.
Option C, Diethylstilbestrol, is associated with serious side effects and is not recommended for hormone replacement therapy in menopausal women due to its link to increased risk of cancer and other health concerns.
In an educational context, understanding the rationale behind the choice of conjugated estrogens for hormone replacement therapy is crucial for healthcare professionals involved in women's health. It highlights the importance of selecting the most appropriate estrogen formulation based on efficacy and safety considerations to provide optimal care for menopausal women experiencing hormonal changes.
Option A, Ethinylestradiol, is not typically used in hormone replacement therapy for menopausal women because it is more commonly found in oral contraceptives.
Option B, Estradiol benzoate, is a form of estradiol that is not as commonly used as conjugated estrogens for hormone replacement therapy in menopausal women.
Option C, Diethylstilbestrol, is associated with serious side effects and is not recommended for hormone replacement therapy in menopausal women due to its link to increased risk of cancer and other health concerns.
In an educational context, understanding the rationale behind the choice of conjugated estrogens for hormone replacement therapy is crucial for healthcare professionals involved in women's health. It highlights the importance of selecting the most appropriate estrogen formulation based on efficacy and safety considerations to provide optimal care for menopausal women experiencing hormonal changes.